Webinar

ENETS-NANETS-Webinar:
Highlights of PRRT and drug development abstracts

Educational Level:

Advanced

Keywords:

Systemic therapy, Clinical trials, GEP NETs, PPGL - pheochromocytomas/paragangliomas, Angiogenesis inhibitors, Radioligand therapy

Downloads:

Agenda:

PART 1: Nuclear medicine / PRRT abstracts

Opening - Rocío GARCIA CARBONERO

Current trials (20 mins)

NETTER 2 trial (10 mins) – Francesa SPADA
Phase 2 Trial of Lu-177-DOTATATE in Metastatic or Inoperable Pheochromocytoma/Paraganglioma: Interim Analysis Results (5 mins) - Alejandro GARCIA ALVAREZ
Neoadjuvant PRRT in pNET (NeoLuPaNET) (5 mins) - Alejandro GARCIA ALVAREZ

Discussion (20 mins)
Panel: Eric BAUDIN, Jennifer CHAN, Rocío GARCIA CARBONERO, Daniel HALPERIN, Frank LIN, Emil LOU, Erik MITTRA, Stefano PARTELLI + presenters

Closing - Rocío GARCIA CARBONERO

BREAK (5 minutes)


PART 2: Multikinase Inhibitors / Drug development

Introduction - Emil LOU

Current trials (20 mins) - Shagufta SHAHEEN

  • CABINET trial
  • NATALIE in Pheo/para
  • (Combination MKI trials) Everolimus + Lenvatinib (ENETS) and CABATEN trial

Discussion (20 mins)
Panel: Eric BAUDIN, Jennifer CHAN, Rocio GARCIA CARBONERO,  Camilo JIMENEZ, Emil LOU+ presenter

Closing - Emil LOU

Moderators:

Rocío GARCÍA CARBONERO
Rocío GARCÍA CARBONERO
Emil LOU
Emil LOU

Speakers:

Francesca SPADA
Francesca SPADA
Alejandro GARCIA ALVAREZ
Alejandro GARCIA ALVAREZ
Shagufta SHAHEEN
Shagufta SHAHEEN
Eric BAUDIN
Eric BAUDIN
Jennifer CHAN
Jennifer CHAN
Daniel HALPERIN
Daniel HALPERIN
Camilo JIMENEZ
Camilo JIMENEZ
Frank LIN
Frank LIN
Eric MITTRA
Eric MITTRA
Stefano PARTELLI
Stefano PARTELLI

The webinar series is intended for HCPs qualified by law to prescribe medicine.

Back to webinar archive